424 related articles for article (PubMed ID: 27340145)
41. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
42. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
[TBL] [Abstract][Full Text] [Related]
43. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
44. Low-dose vasopressin in the treatment of septic shock in sheep.
Sun Q; Dimopoulos G; Nguyen DN; Tu Z; Nagy N; Hoang AD; Rogiers P; De Backer D; Vincent JL
Am J Respir Crit Care Med; 2003 Aug; 168(4):481-6. PubMed ID: 12791578
[TBL] [Abstract][Full Text] [Related]
45. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
[TBL] [Abstract][Full Text] [Related]
46. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
47. Selepressin, a novel selective vasopressin V
Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
[TBL] [Abstract][Full Text] [Related]
48. Central venous pressure value can assist in adjusting norepinephrine dosage after the initial resuscitation of septic shock.
Li DK; Du W
Chin Med J (Engl); 2019 May; 132(10):1159-1165. PubMed ID: 30946069
[TBL] [Abstract][Full Text] [Related]
49. Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
Brask AL; Shemanski SM; Barnes TE; Holmes AK
Ann Pharmacother; 2023 May; 57(5):521-526. PubMed ID: 36039490
[TBL] [Abstract][Full Text] [Related]
50. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
51. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series.
Holmes CL; Walley KR; Chittock DR; Lehman T; Russell JA
Intensive Care Med; 2001 Aug; 27(8):1416-21. PubMed ID: 11511958
[TBL] [Abstract][Full Text] [Related]
52. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
53. A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
He X; Su F; Taccone FS; Laporte R; Kjølbye AL; Zhang J; Xie K; Moussa MD; Reinheimer TM; Vincent JL
Crit Care Med; 2016 Jan; 44(1):23-31. PubMed ID: 26496451
[TBL] [Abstract][Full Text] [Related]
54. [Role of vasopressin in septic shock : critical evaluation].
Gradwohl-Matis I; Brunauer A; Dankl D; Dünser M
Anaesthesist; 2014 Jun; 63(6):503-10. PubMed ID: 24838480
[TBL] [Abstract][Full Text] [Related]
55. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
Saad AF; Maybauer MO
J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
[TBL] [Abstract][Full Text] [Related]
56. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
Gordon AC; Wang N; Walley KR; Ashby D; Russell JA
Chest; 2012 Sep; 142(3):593-605. PubMed ID: 22518026
[TBL] [Abstract][Full Text] [Related]
57. Push-Dose Vasopressin for Hypotension in Septic Shock.
Nowadly CD; Catlin JR; Fontenette RW
J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
[TBL] [Abstract][Full Text] [Related]
58. Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock.
Kim EH; Lee SH; Byun SW; Kang HS; Koo DH; Park HG; Hong SB
Korean J Intern Med; 2006 Dec; 21(4):287-90. PubMed ID: 17249516
[TBL] [Abstract][Full Text] [Related]
59. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
[TBL] [Abstract][Full Text] [Related]
60. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
Sacha GL; Bauer SR
Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
